Development of the Sleeping Pills Receptivity and Involuntariness Scale-6 (SPRIS-6) to Assess Acceptance of Hypnotics Use
Open Access
- 1 September 2025
- journal article
- research article
- Published by Taylor & Francis in Nature and Science of Sleep
- Vol. ume 17, 2309-2319
Abstract
Background: Assessing an individual’s acceptance of sleep medications is valuable for clinicians, as it may be the starting point for discussing the treatment of insomnia, whether pharmacologically or nonpharmacologically. This study developed a rating scale for measuring psychological receptivity to hypnotics and validated it in a general population. Methods: We conducted an anonymous survey in a general Korean population. First, we developed a rating scale for psychological receptivity to hypnotic use using exploratory factor analysis (EFA) in Sample I (N = 300), followed by confirmatory factor analysis (CFA) in Sample II (N = 300). Convergent validity was assessed using the Insomnia Severity Index (ISI), Glasgow Sleep Effort Scale (GSES), Adaptive Cognition and Behaviors about Sleep-6 (ACBS-6), and Acceptance and Action Questionnaire-II (AAQ-II). Results: From the EFA, six survey items were selected from the collected items. The CFA among Sample II showed a good fit for the two-factor model (Factor 1: Involuntary nature of insomnia; Factor 2: Acceptance of sleep medication use) of our Sleeping Pills Receptivity and Involuntariness Scale-6 (SPRIS-6) (comparative fit index = 0.99, Tucker–Lewis index = 0.99, root-mean-square-error of approximation = 0.02, and standardized root-mean-square residual = 0.02). According to the multi-group CFA, the two-factor structure of the SPRIS-6 measures psychological receptivity to sleep medications in the same way, regardless of whether or not participants reported insomnia. Using McDonald’s coefficient of 0.80, the two-factor structure of the SPRIS-6 demonstrated good internal consistency. Linear regression analysis showed that the ISI score was positively influenced by the SPRIS-6 (β = 0.16, p = 0.002), GSES (β = 0.49, p = 0.001), and AAQ-II (β = 0.18, p = 0.001), whereas it was inversely influenced by the ACBS-6 (β = − 0.10, p = 0.037). Conclusion: The SPRIS-6 is a reliable and valid rating scale that measures psychological receptivity to sleep medication use.Keywords
This publication has 30 references indexed in Scilit:
- Development of the Adaptive Cognition and Behaviors about Sleep-6 (ACBS-6) for sleep-related conditions or behaviors diminishing insomnia severitySleep Medicine, 2025
- Development and validation of the Japanese version of the Restorative Sleep Questionnaire in community samplesSleep Medicine, 2023
- Melatonin for sleep disorders in people with autism: Systematic review and meta-analysisProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2022
- Effects of aging on slow-wave sleep dynamics and human spatial navigational memory consolidationNeurobiology of Aging, 2016
- Prefrontal atrophy, disrupted NREM slow waves and impaired hippocampal-dependent memory in agingNature Neuroscience, 2013
- Preliminary Psychometric Properties of the Acceptance and Action Questionnaire–II: A Revised Measure of Psychological Inflexibility and Experiential AvoidanceBehavior Therapy, 2011
- Validation of the Insomnia Treatment Acceptability Scale (ITAS) in Primary CareJournal of Clinical Psychology in Medical Settings, 2011
- The Insomnia Severity Index: Psychometric Indicators to Detect Insomnia Cases and Evaluate Treatment ResponseSLEEP, 2011
- Rasch analysis of a new stroke-specific outcome scale: the stroke impact scale11No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit upon the author(s) or upon any organization with which the author(s) is/are associated.Archives of Physical Medicine and Rehabilitation, 2003
- A Behavioral Perspective on Insomnia TreatmentPsychiatric Clinics of North America, 1987